The increasing reliance on biopharmaceuticals, including vaccines, gene therapies, and monoclonal antibodies, that require advanced microbial processes for production is one of the major factors boosting the market growth. Moreover, the growing utilization of microbial fermentation in synthesizing therapeutic proteins, enzymes, and antibodies is catalyzing the market growth. Along with this, the heightened surge in demand for microbial fermentation technologies and products, as these techniques offer precision and high yield, is fueling the market growth. Visit us: https://www.imarcgroup.com/ind....ustrial-microbiology